Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease

被引:41
|
作者
Schumacher, Julia [1 ]
Ray, Nicola J. [2 ]
Hamilton, Calum A. [1 ]
Donaghy, Paul C. [1 ]
Firbank, Michael [1 ]
Roberts, Gemma [1 ]
Allan, Louise [1 ,3 ]
Durcan, Rory [1 ]
Barnett, Nicola [1 ]
O'Brien, John T. [4 ]
Taylor, John-Paul [1 ]
Thomas, Alan J. [1 ]
机构
[1] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Biomed Res Bldg 3rd Floor,Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[2] Manchester Metropolitan Univ, Hlth Psychol & Communities Res Ctr, Dept Psychol, Manchester, Lancs, England
[3] Univ Exeter, Inst Hlth Res, Exeter, Devon, England
[4] Univ Cambridge, Dept Psychiat, Sch Med, Cambridge CB2 0SP, England
基金
英国惠康基金;
关键词
nucleus basalis of Meynert; basal forebrain; mild cognitive impairment; diffusion-weighted imaging; probabilistic tractography; BASAL FOREBRAIN ATROPHY; DIFFEOMORPHIC IMAGE REGISTRATION; MILD COGNITIVE IMPAIRMENT; NUCLEUS BASALIS; SUBSTANTIA INNOMINATA; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; PARKINSONS-DISEASE; NATIONAL INSTITUTE; BRAIN;
D O I
10.1093/brain/awab372
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients who have dementia with Lewy bodies and Alzheimer's disease show early degeneration of the cholinergic nucleus basalis of Meynert. However, how white matter projections between the nucleus basalis of Meynert and the cortex are altered in neurodegenerative disease is unknown. Tractography of white matter pathways originating from the nucleus basalis of Meynert was performed using diffusion-weighted imaging in 46 patients with Alzheimer's disease dementia, 48 with dementia with Lewy bodies, 35 with mild cognitive impairment with Alzheimer's disease, 38 with mild cognitive impairment with Lewy bodies and 71 control participants. Mean diffusivity of the resulting pathways was compared between groups and related to cognition, attention, functional EEG changes and dementia conversion in the mild cognitive impairment groups. We successfully tracked a medial and a lateral pathway from the nucleus basalis of Meynert. Mean diffusivity of the lateral pathway was higher in both dementia and mild cognitive impairment groups than controls (all P < 0.03). In the patient groups, increased mean diffusivity of this pathway was related to more impaired global cognition (beta = -0.22, P = 0.06) and worse performance on an attention task (beta = 0.30, P = 0.03). In patients with mild cognitive impairment, loss of integrity of both nucleus basalis of Meynert pathways was associated with increased risk of dementia progression [hazard ratio (95% confidence interval), medial pathway: 2.51 (1.24-5.09); lateral pathway: 2.54 (1.24-5.19)]. Nucleus basalis of Meynert volume was reduced in all clinical groups compared to controls (all P < 0.001), but contributed less strongly to cognitive impairment and was not associated with attention or dementia conversion. EEG slowing in the patient groups as assessed by a decrease in dominant frequency was associated with smaller nucleus basalis of Meynert volumes (beta = 0.22, P = 0.02) and increased mean diffusivity of the lateral pathway (beta = -0.47, P = 0.003). We show that degeneration of the cholinergic nucleus basalis of Meynert in Alzheimer's disease and dementia with Lewy bodies is accompanied by an early reduction in integrity of white matter projections that originate from this structure. This is more strongly associated with cognition and attention than the volume of the nucleus basalis of Meynert itself and might be an early indicator of increased risk of dementia conversion in people with mild cognitive impairment.
引用
收藏
页码:1773 / 1784
页数:12
相关论文
共 50 条
  • [41] Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease
    Ballmaier, M
    Memo, M
    FUNCTIONAL NEUROLOGY, 2005, 20 (02) : 69 - 69
  • [42] Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease
    Tiraboschi, P
    Hansen, LA
    Alford, M
    Merdes, A
    Masliah, E
    Thal, LJ
    Corey-Bloom, J
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (10) : 946 - 951
  • [43] The cholinergic basal forebrain in Lewy body dementia and Alzheimer’s disease
    Kurt A. Jellinger
    Journal of Neurology, 2015, 262 : 479 - 480
  • [44] The cholinergic basal forebrain in Lewy body dementia and Alzheimer's disease
    Jellinger, Kurt A.
    JOURNAL OF NEUROLOGY, 2015, 262 (02) : 479 - 480
  • [45] The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia
    Li, Xudong
    Shen, Miaoxin
    Han, Ziling
    Jiao, Jinsong
    Tong, Xiaopeng
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [46] Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia
    Walker, MP
    Ayre, GA
    Cummings, JL
    Wesnes, K
    McKeith, IG
    O'Brien, JT
    Ballard, CG
    NEUROLOGY, 2000, 54 (08) : 1616 - 1624
  • [47] Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies
    Tremblay, Cecilia
    Shakir, Neha
    Zhang, Nan
    Adler, Charles H.
    Shill, Holly A.
    Mehta, Shyamal
    Driver-Dunckley, Erika
    Belden, Christine M.
    Atri, Alireza
    Beach, Thomas G.
    Serrano, Geidy E.
    Choudhury, Parichita
    JOURNAL OF ALZHEIMERS DISEASE, 2025,
  • [48] Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
    Francis, Paul T.
    Perry, Elaine K.
    MOVEMENT DISORDERS, 2007, 22 : S351 - S357
  • [49] α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores
    Bayer, TA
    Jäkälä, P
    Hartmann, T
    Havas, L
    McLean, C
    Culvenor, JG
    Li, QX
    Masters, CL
    Falkai, P
    Beyreuther, K
    NEUROSCIENCE LETTERS, 1999, 266 (03) : 213 - 216
  • [50] Differentiating dementia with Lewy bodies and Alzheimer's disease using MRI
    Watson, Rosie
    O'Brien, John T.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (04) : 411 - 420